Harriet Kluger, MD
Yale University
5
5
3
N/A
0
7
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Sarah Weiss, MD
Yale University
Shared therapeutic areas:
Worked with same sponsors:
Kelly Olino, MD
Yale University
Shared therapeutic areas:
Worked with same sponsors:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Zhaohui Zhu, MD
Peking Union Medical College Hospital
Shared therapeutic areas:
E-mail: ClinicalTrials@ ImClone.com
Eli Lilly and Company
Shared therapeutic areas:
Worked with same sponsors:
howard Safran, MD
Brown University
Shared therapeutic areas:
Worked with same sponsors:
James L Gulley, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Michael B Gill
Power Life Sciences Inc.
Shared therapeutic areas:
David S Schrump, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Brigitte C Widemann, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment NaĂ¯ve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)
APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma
MK-3475 in Melanoma and NSCLC Patients With Brain Metastases
Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis
All 5 trials loaded